Toth Financial Advisory Corp Vir Biotechnology, Inc. Transaction History

Toth Financial Advisory Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$22.26 - $30.85 $445 - $617	-20 Reduced 50.0%	20 $0
Q3 2021 Oct 20, 2021	BUY	$34.9 - $54.54 $1,396 - $2,181	40 New	40 $2,000
Q1 2021 Apr 20, 2021	SELL	$26.34 - $83.07 $3,160 - $9,968	-120 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$25.51 - $43.38 $1,785 - $3,036	70 Added 140.0%	120 $3,000
Q2 2020 Jul 14, 2020	BUY	$27.89 - $47.86 $1,394 - $2,393	50 New	50 $2,000

231

90.1M

1.28M

235K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.27B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.